Skip to main content
Journal cover image
Genomic and Precision Medicine: Primary Care: Third Edition

Health Risk Assessments, Family Health History, and Predictive Genetic/Pharmacogenetic Testing

Publication ,  Chapter
Bregendahl, ME; Orlando, LA; Palaniappan, L
March 23, 2017

Primary care, the first point of contact for patients, is in an ideal position to promote integration of genomic medicine in wider healthcare use. Most primary-care physicians spend a majority of their time treating chronic conditions. The discovery of genetic variations underlying these chronic diseases offers them the unprecedented opportunity to personalize disease prediction and treatment. In the electronic health record era, health risk assessments with an accurate family history, medication reconciliation, and physician decision support for genetic and pharmacogenetic testing using evidenced-based guidelines should be incorporated into health systems and clinical workflows. This chapter will discuss the importance of these innovations in transforming primary care.

Duke Scholars

DOI

ISBN

9780128006856

Publication Date

March 23, 2017

Start / End Page

75 / 88
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bregendahl, M. E., Orlando, L. A., & Palaniappan, L. (2017). Health Risk Assessments, Family Health History, and Predictive Genetic/Pharmacogenetic Testing. In Genomic and Precision Medicine: Primary Care: Third Edition (pp. 75–88). https://doi.org/10.1016/B978-0-12-800685-6.00003-5
Bregendahl, M. E., L. A. Orlando, and L. Palaniappan. “Health Risk Assessments, Family Health History, and Predictive Genetic/Pharmacogenetic Testing.” In Genomic and Precision Medicine: Primary Care: Third Edition, 75–88, 2017. https://doi.org/10.1016/B978-0-12-800685-6.00003-5.
Bregendahl ME, Orlando LA, Palaniappan L. Health Risk Assessments, Family Health History, and Predictive Genetic/Pharmacogenetic Testing. In: Genomic and Precision Medicine: Primary Care: Third Edition. 2017. p. 75–88.
Bregendahl, M. E., et al. “Health Risk Assessments, Family Health History, and Predictive Genetic/Pharmacogenetic Testing.” Genomic and Precision Medicine: Primary Care: Third Edition, 2017, pp. 75–88. Scopus, doi:10.1016/B978-0-12-800685-6.00003-5.
Bregendahl ME, Orlando LA, Palaniappan L. Health Risk Assessments, Family Health History, and Predictive Genetic/Pharmacogenetic Testing. Genomic and Precision Medicine: Primary Care: Third Edition. 2017. p. 75–88.
Journal cover image

DOI

ISBN

9780128006856

Publication Date

March 23, 2017

Start / End Page

75 / 88